iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF – Get Free Report)’s share price crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $40.38 and traded as high as $41.36. iShares LifePath Target Date 2050 ETF shares last traded at $41.28, with a volume of 24,557 shares trading hands.
iShares LifePath Target Date 2050 ETF Stock Up 2.5%
The business’s fifty day moving average is $41.73 and its 200-day moving average is $40.38. The company has a market cap of $100.72 million, a PE ratio of 20.56 and a beta of 0.87.
Institutional Investors Weigh In On iShares LifePath Target Date 2050 ETF
Institutional investors and hedge funds have recently bought and sold shares of the business. Integrated Wealth Concepts LLC purchased a new position in iShares LifePath Target Date 2050 ETF in the 2nd quarter worth approximately $1,206,000. Harbour Investments Inc. bought a new position in iShares LifePath Target Date 2050 ETF in the 3rd quarter worth approximately $439,000. 10Elms LLP boosted its stake in iShares LifePath Target Date 2050 ETF by 10.5% in the 3rd quarter. 10Elms LLP now owns 2,878 shares of the company’s stock worth $120,000 after purchasing an additional 274 shares during the period. Finally, Sound Financial Strategies Group LLC purchased a new stake in iShares LifePath Target Date 2050 ETF during the 2nd quarter valued at approximately $225,000.
About iShares LifePath Target Date 2050 ETF
The iShares LifePath Target Date 2050 ETF USD (ITDF) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2050. ITDF was launched on Oct 17, 2023 and is issued by BlackRock.
Recommended Stories
- Five stocks we like better than iShares LifePath Target Date 2050 ETF
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for iShares LifePath Target Date 2050 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2050 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
